LWAC
NARI

Laurel Wealth Advisors (California)’s Inari Medical, Inc. Common Stock NARI Stock Holding History

Laurel Wealth Advisors (California)’s Portfolio NARI Stock Details NARI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-2,290
Closed -$208K – 766
2022
Q1 		$208K Hold
2,290
– – 0.02% 712
2021
Q4 		$209K Buy
+2,290
New +$196K 0.02% 749

Other funds holding NARI

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $59.7B AUM 29.08% 1-Year Est. Return

Laurel Wealth Advisors (California)'s NARI Position: Q2 2022 in Review

Laurel Wealth Advisors (California) sold out of Inari Medical, Inc. Common Stock (NARI) in Q2 2022, closing a stake of 2,290 shares — an estimated $208K sold.

Laurel Wealth Advisors (California) first reported a position in NARI in Q4 2021 and held it in 2 quarters. The position peaked at $209K in Q4 2021. 227 funds tracked by Wall St. Rank hold NARI as of Q2 2022.

  • Laurel Wealth Advisors (California) reported no remaining Inari Medical, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Laurel Wealth Advisors (California) sold 2,290 Inari Medical, Inc. Common Stock shares in Q2 2022, an estimated $208K.
  • Laurel Wealth Advisors (California) first reported a position in Inari Medical, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Laurel Wealth Advisors (California)'s Inari Medical, Inc. Common Stock position peaked at $209K in Q4 2021.
  • 227 funds tracked by Wall St. Rank held Inari Medical, Inc. Common Stock as of Q2 2022.

Based on Laurel Wealth Advisors (California)'s 13F filing for Q2 2022, filed 12 Aug 2022.